social icon social icon social icon
Cannabis Users Have Lower Obesity Rates. Here's the Data.

Cannabis Users Have Lower Obesity Rates. Here's the Data.

Cannabis Users Have Lower Obesity Rates. Here's the Data.

America is spending $800 a month on injectable weight loss drugs.

Roughly one in eight American adults has now used a GLP-1 medication. Ozempic and Wegovy have become the defining pharmaceutical story of the decade: promise and risk packed into a weekly injection, marketed as the answer to a public health crisis that's been building since the 1970s.

Meanwhile, a quieter body of research has been accumulating for years. Peer-reviewed studies across hundreds of thousands of participants consistently find the same thing: cannabis users have lower rates of obesity than non-users. They gain less weight over time. And contrary to every lazy stoner stereotype, they exercise more.

The punchline writes itself. But the science is real.

The Numbers Are Difficult to Ignore

Let's start with the data.

A study drawing on a nationally representative sample of nearly 736,000 participants found that current marijuana users are 31 percent less likely to be obese than non-users. Daily users are 32 percent less likely. The relationship held after adjustment for confounders including age, sex, race, income, and smoking status.

The BMI numbers are concrete. Across studies reporting body mass index, the mean BMI of non-users was 27.5 kg/m², firmly in the "overweight" range. The mean BMI of cannabis users was 26.0 kg/m². Among the heaviest users, BMI dropped to 25.5 kg/m². That's a 2-point difference that represents, at population scale, millions of people.

A prospective 3-year study published in the International Journal of Epidemiology followed participants over time and found something even more striking: everyone gained weight over the study period. But cannabis users gained significantly less. Over three years, persistent cannabis users showed attenuated BMI increases compared to never-users, even after controlling for lifestyle variables.

The data suggests this isn't a snapshot effect. It tracks over time.

The Munchies Paradox (And Why It's Not Actually Paradoxical)

The obvious counterargument is appetite. Cannabis increases appetite. The "munchies" are pharmacologically real, driven by THC's activation of CB1 receptors in the hypothalamus. So how do users end up leaner?

The answer lies in the endocannabinoid system (ECS) itself.

Research published in PMC (National Institutes of Health) proposes a mechanism: chronic cannabis use triggers rapid and lasting downregulation of CB1 receptors. When CB1 receptors are persistently exposed to cannabinoids, the body reduces their density and sensitivity, a standard adaptive response. The effect of this downregulation is reduced energy storage and increased metabolic rate.

In simpler terms: regular cannabis use may recalibrate the ECS toward a leaner metabolic set point, partially offsetting both the appetite-stimulating effects of acute THC exposure and the broader metabolic dysregulation associated with obesity.

A 2024 study published in Pharmacology Research & Perspectives found that CBD functions as a negative allosteric modulator of CB1 receptors, blocking strong agonist binding and producing metabolic effects that include fat browning, reduced lipid accumulation, and improved insulin sensitivity. THCV, another cannabinoid found in hemp, demonstrated decreased appetite, increased energy expenditure, and improved glucose tolerance in multiple preclinical models.

The ECS isn't incidentally connected to body weight. It is one of the primary regulatory systems the body uses to manage energy homeostasis, appetite, and fat storage. Cannabis doesn't circumvent this system. It engages it.

Cannabis Users Exercise More. That's Not Incidental.

Weight and movement are inseparable, which makes the physical activity data worth examining alongside the BMI data.

A federally funded study, covered by Marijuana Moment and replicated by research published in the Journal of Cannabis Research, found that people are more physically active on days they use cannabis. Not less. More.

Frequent cannabis users engaged in greater physical activity than non-current users. Light cannabis users had higher odds of self-reporting regular exercise. The findings were particularly pronounced among adults over 40 and among non-smokers. In states with legal recreational cannabis access, the association between use and physical activity was strongest.

When researchers asked cannabis users why they used before or during exercise, the top responses were: "helping to focus/concentrate" (66%), "helping enjoy the exercise experience" (65%), and "enhancing mind-body-spirit connection" (65%).

This aligns with what we know about the ECS and exercise. The ECS, specifically anandamide elevation, is the primary mechanism behind exercise's mood-elevating, depression-protective effects. Cannabinoids support the same receptor system that makes movement feel rewarding. That's not coincidence. It's mechanism.

If cannabis makes exercise more enjoyable, and regular exercise reduces obesity, then the epidemiological data showing lower BMI in cannabis users starts to make a lot of biological sense.

Meanwhile, the GLP-1 Picture Is Getting More Complicated

GLP-1 receptor agonists are effective pharmaceutical tools for significant, rapid weight loss in clinical populations with obesity-related comorbidities. That clinical utility is real.

But the longer the data accumulates, the more complicated the risk-benefit calculus becomes for the millions of people using these drugs primarily for cosmetic weight management.

On muscle loss: Research confirmed that roughly 40 percent of the weight lost on GLP-1 drugs is lean muscle mass, not fat. When users stop the medication and regain weight, the regained mass is almost exclusively fat. Many patients end up with a worse body composition ratio after a treatment cycle than before it began.

On weight rebound: A 2026 review found that most people regain the majority of their lost weight within one to two years of stopping GLP-1 medications. The drugs appear to require indefinite use to maintain results, creating a permanent pharmaceutical dependency for a condition that is, in many cases, addressable through lifestyle.

On cost: GLP-1 medications currently run between $349 and $800 per month in the United States. Americans pay 2 to 4 times more than patients in Europe for the same medications.

On side effects: Nausea, vomiting, diarrhea, and constipation affect roughly 50% of users. Gallstone formation occurs in 2 to 4% of clinical trial participants. Rare but serious risks include pancreatitis and acute kidney injury.

None of this makes GLP-1s bad drugs. It makes them powerful interventions with trade-offs, tools appropriate for clinical weight management under medical supervision, not lifestyle supplements for people who want to feel better on their morning run.

What This Means for How You Think About Movement

The obesity crisis is real. The pharmaceutical industry's response to it is, in many ways, a good-faith attempt to solve a problem that diet and exercise advice has clearly failed to crack at population scale.

But the data emerging from cannabis research points toward a different frame entirely. Rather than suppressing appetite pharmacologically, what if supporting the body's own metabolic regulation system, the ECS, through movement, sleep, recovery, and targeted cannabinoid supplementation produced durable results without the $800/month price tag or the muscle-loss tradeoff?

The answer isn't fully written yet. Cannabis research has historically been underfunded due to federal prohibition, and the long-term metabolic studies needed to confirm causality (not just correlation) haven't been done at scale. The current data is association, not intervention.

But the direction of the evidence is consistent: people who use cannabis tend to weigh less, gain weight more slowly, and exercise more often than people who don't. The biological mechanisms through which the ECS regulates metabolism, appetite, and the reward value of physical activity are established science.

That's a foundation worth building on.

The OFFFIELD Approach

OFFFIELD's High Performance Energy Gummies are formulated for people who already exercise, or want to. The blend of 3mg THC, 10mg CBG, and 40mg CBD isn't designed to suppress appetite or mimic a pharmaceutical intervention. It's designed to support the ECS pathways that make movement more enjoyable, focus sharper, and the post-workout window more productive.

Recovery happens at night. The High Performance Sleep Gummies (2mg THC, 20mg CBD, 20mg CBN, with magnesium glycinate and L-theanine) support the deep sleep in which muscle repair, hormone regulation, and metabolic reset occur.

The whole picture is on the science page. Movement made happy. A system that's already working, supported and not replaced.

FAQ: Cannabis, Obesity, and Metabolic Health

Do cannabis users really have lower obesity rates?
Yes. Multiple large-scale studies, including one of 736,000 participants, consistently find that cannabis users have lower BMI and lower obesity rates than non-users. Daily users show a 32% lower likelihood of obesity.

How does cannabis affect body weight if it increases appetite?
The leading hypothesis is CB1 receptor downregulation. Chronic cannabis exposure reduces receptor density and sensitivity, attenuating energy storage and increasing metabolic rate, partially offsetting acute appetite stimulation.

Do cannabis users exercise more or less than non-users?
Research finds cannabis users are more physically active on days of use and more likely to report regular exercise. This may be because cannabinoids support the ECS pathways that make movement feel rewarding.

Is cannabis a safer alternative to Ozempic for weight management?
This is not an appropriate comparison for most people. GLP-1 drugs are prescription medications for clinical obesity. Cannabis is not FDA-approved for weight management, and the current BMI data is observational, not from controlled intervention trials. What the data does show is a consistent, population-level association between cannabis use and healthier body weight, along with a biological mechanism worth continued research.

What cannabinoids are most relevant to metabolism?
CBD (negative CB1 modulator, anti-inflammatory, may support fat browning), CBG (anti-inflammatory, CB1/CB2 activity), and THCV (appetite suppression, improved insulin sensitivity in preclinical models) all show metabolic relevance in peer-reviewed research.


Legal Disclaimer: These statements have not been evaluated by the Food and Drug Administration. OFFFIELD products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. The research cited describes associations in observational studies and does not constitute medical advice. Hemp-derived products contain ≤0.3% delta-9 THC in compliance with the 2018 Farm Bill. Consult a healthcare professional before beginning any supplement regimen or making changes to an existing medication plan. Not intended for use by individuals under 21 years of age.


Sources

  1. NORML: Study, Cannabis Use Correlated With Lower Rates of Obesity (2024)
  2. PMC/NIH: Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users
  3. PubMed: Are cannabis users less likely to gain weight? Results from a national 3-year prospective study. International Journal of Epidemiology, 2019.
  4. PMC/NIH: Association between cannabis use and physical activity in the United States. Journal of Cannabis Research, 2024.
  5. PMC/NIH: The endocannabinoid system in appetite regulation and treatment of obesity. Pharmacology Research & Perspectives, 2024.
  6. ScienceDaily: GLP-1 drugs deliver huge weight loss but new research reveals a hidden catch (2025)
  7. CNN: Many people who come off GLP-1 drugs regain weight within 2 years (2026)
CBG: The Mother Cannabinoid for Focus and Clean Energy

Everyone has met CBD by now. It is on the gas station counter, in the seltzer, folded into the post-yoga conversation. But the cannabinoid that quietly makes CBD possible has spent most of that time backstage. That cannabinoid is CBG, and in 2026 it is finally stepping into the light.

CBG, short for cannabigerol, is having its breakout year. Search interest in "what is CBG" keeps climbing, supplement brands are scrambling to add it, and athletes who already understand CBD are asking a sharper question: if CBD calms, what gives me clean focus without the wired edge of another espresso? The answer keeps pointing back to the molecule the cannabis plant builds first.

What Is CBG, the Mother Cannabinoid

Here is the part that surprises people. Every cannabinoid in the plant starts as one thing. The cannabis plant produces CBGA, the acidic form of CBG, and enzymes then convert it into the precursors of THC, CBD, and the rest. CBG is the source. That is why researchers and growers call it the mother cannabinoid, or the "mother of all cannabinoids."

Because the plant converts most of its CBGA into other compounds as it matures, mature flower usually contains less than one percent CBG. It is rare, it is expensive to isolate, and for years that scarcity kept it out of the conversation. Extraction and breeding have caught up, and now CBG can stand on its own.

CBG is non-intoxicating. It will not get you high. What makes it interesting is how it works in the body, which is different enough from CBD to matter.

What the Research Actually Shows

CBG interacts with the endocannabinoid system (ECS), the network of receptors that helps regulate inflammation, mood, appetite, and recovery. Unlike CBD, which mostly works indirectly, CBG binds more directly to the CB1 and CB2 receptors and also engages alpha-2 adrenergic receptors, the same family involved in focus and alertness. That receptor profile is part of why CBG is associated with a sharper, more awake feeling rather than a sedating one.

The inflammation story is the most developed. A 2025 review in Frontiers in Pharmacology catalogued cannabigerol's antioxidant and anti-inflammatory activity across the cardiovascular system, noting its ability to dampen inflammatory signaling in preclinical models. Broader reviews of the cannabinoid describe consistent suppression of inflammatory cytokines, the same chemical messengers that flare after a hard training block and slow you down the next day.

The honest caveat: most CBG research today is preclinical, meaning laboratory and animal studies rather than large human trials. The signal is promising and consistent, but the field is young. Anyone selling CBG as a cure is getting ahead of the evidence. What the data supports right now is a credible mechanism for lower inflammation and improved focus, which is exactly what an athlete wants from a daytime cannabinoid.

Why Focus Is the Story Athletes Care About

Caffeine works. It also overshoots. The jitter, the 3 p.m. crash, the second cup that turns a good warmup into a racing heart at the start line. Most active people are not looking for more stimulation. They are looking for cleaner stimulation, the kind that sharpens attention without hijacking it.

This is where CBG earns its place. Stacked with a moderate dose of natural caffeine, CBG appears to smooth the experience, supporting alertness while the ECS engagement keeps the edge off. It is less "floor it" and more "find the right gear." For a lifter dialing in a heavy set, a runner settling into tempo pace, or anyone who just needs to be present for a hard hour, that distinction is everything.

It also fits the larger truth OFFFIELD keeps coming back to. The Runner's High is not an endorphin myth, it is an endocannabinoid event. Your best sessions are already an ECS phenomenon. Supporting that system with the right exogenous cannabinoids is not a hack, it is working with the body's own chemistry instead of against it.

CBG in the OFFFIELD Stack

This is why CBG is not a footnote in our formulas, it is a load-bearing ingredient. Our High Performance Energy Gummies pair 10mg of CBG with 40mg CBD, a low 3mg of THC, and 10mg of natural caffeine from yerba mate. The CBG and caffeine handle focus and drive, the CBD supports recovery and keeps inflammation in check, and the trace THC adds the enjoyment that makes you actually want to lace up again.

Prefer to skip THC entirely? The Enhanced Energy Gummies are THC-free and build the same idea around 50mg CBD, 8mg CBG, and 15mg natural caffeine. Same philosophy, different dial setting. Either way, CBG is doing quiet, unglamorous work in the background, which is fitting for the molecule that builds everything else.

CBG and CBD Are Not Rivals

It is tempting to frame CBG as the new thing replacing CBD. That misses the point. They are teammates. CBD is the broad, calming, recovery-leaning cannabinoid. CBG is the focused, alert, inflammation-targeting one. Together they cover more of the day than either does alone, which is why thoughtful formulas use both rather than picking a side.

The mother cannabinoid spent years building the rest of the family and getting none of the credit. In 2026 it is finally getting its due, not because of hype, but because the way it works lines up neatly with what active people actually need: focus that does not fray, and recovery that keeps showing up.

Frequently Asked Questions

What is CBG?
CBG, or cannabigerol, is a non-intoxicating cannabinoid known as the "mother cannabinoid" because the plant produces it first and then converts it into CBD, THC, and others. It is associated with focus and anti-inflammatory effects.

Does CBG get you high?
No. CBG is non-intoxicating. It will not produce the high associated with THC.

What is the difference between CBG and CBD?
CBD tends to be calming and recovery-oriented and works mostly indirectly on the endocannabinoid system. CBG binds more directly to cannabinoid receptors and engages focus-related pathways, so it is often associated with alertness rather than sedation.

Is CBG good for working out?
Early research points to anti-inflammatory and focus-supporting properties, which is why CBG is showing up in pre-workout formulas alongside caffeine. Most studies are still preclinical, so treat it as a promising support, not a miracle.


Movement Made Happy. Train with focus, recover faster, and enjoy every session. Explore the High Performance Energy Gummies or dig into the mechanism on our Science page.

Related reading:

Legal disclaimer: This content is for informational purposes only and is not medical advice. OFFFIELD products are hemp-derived and contain federally compliant levels of THC. CBG research is largely preclinical and ongoing. Consult a healthcare professional before use, especially if pregnant, nursing, or taking medication. Do not drive or operate machinery after use. Keep out of reach of children. Not for use by anyone under 21.

article image
Sober Curious Summer: Why Active People Are Trading Beer for Low-Dose THC

The post-run beer used to be sacred. You logged your miles, you earned your pint, and the patio session afterward was half the reason you showed up. But hang around a run club meetup this summer and you'll notice the ritual has changed: precision-dosed gummies passed around like orange slices at halftime, and a lot fewer cans of anything.

This is the sober curious movement hitting its stride. Low-dose hemp products are now one of the fastest-growing corners of the cannabis market. According to BDSA consumer data, 42% of edible consumers prefer 10mg of THC or less per occasion, with 2.5mg to 5mg the most common choice. The people driving this shift are not stoners. They are the ones setting PRs.

Alcohol Charges Interest on Every Workout

Here's the uncomfortable math the fitness world has started doing out loud. Alcohol is not just empty calories. It actively works against the training you just did.

A frequently cited study in PLOS ONE found that alcohol consumed after exercise reduced muscle protein synthesis rates, even when athletes ate protein alongside it. Translation: the beer after your lift partially undoes the lift.

Then there's sleep. Alcohol fragments REM sleep and suppresses the deep stages where physical recovery actually happens. You fall asleep faster but recover worse. Stack three or four drinking nights a week on top of a training plan and you are essentially running with a parachute.

The sober curious crowd did not need a lecture about any of this. They just noticed they felt better, trained harder, and stopped losing Saturdays to hangovers. Harvard Health's comparison of cannabis and alcohol captures the core appeal: a social buzz without the dehydration, the calories, or the next-day tax.

Low-Dose THC Works With Your Biology, Not Against It

This is where the science gets interesting. Alcohol is a blunt instrument that depresses your central nervous system. Cannabinoids interact with something your body already built for movement: the endocannabinoid system (ECS).

The ECS is the network of receptors and signaling molecules responsible for the Runner's High. Research over the past decade has shown that endocannabinoids like anandamide, not endorphins, are the primary drivers of that post-exercise euphoria. Exercise raises your endocannabinoid levels naturally. Low-dose exogenous cannabinoids like THC, CBD, and CBG engage that same system.

A landmark University of Colorado Boulder study published in Sports Medicine found that runners who used cannabis before exercise reported greater enjoyment and a stronger runner's high during their workouts, without perceiving the effort as harder. The participants were not getting blasted before a 5K. They were using modest doses to make movement feel better.

That's the distinction the sober curious movement understands intuitively. At 2.5mg to 5mg, THC is social lubrication and mood elevation. At 50mg, it's a couch. Dose is everything, which is why the low-dose format is winning.

The Patio Test: What Social Fitness Looks Like in 2026

Run clubs have become the new dating apps. Pickleball leagues are booked out weeks in advance. Group fitness is the social architecture of this decade, and it created a problem alcohol could never solve: nobody wants to feel like garbage at tomorrow's session.

So the post-activity ritual evolved. Fox Business reported this month that low-dose THC has become the buzz of the summer, driven largely by people cutting back on alcohol without going fully sober. And a gummy fits the moment better than any can ever did: it travels in a running vest, it doesn't need a cooler, and it says you're still here for the hang.

A 3mg gummy passes the patio test. You're present, you're elevated, you're laughing at the group chat recap. And at 6 a.m. when your training plan says tempo run, you're actually at the tempo run.

Precision Dosing Is the Whole Point

The lesson of the low-dose revolution is that cannabinoids reward precision. This is exactly the philosophy behind OFFFIELD's High Performance Energy Gummies: 3mg THC, 10mg CBG, 40mg CBD, and 10mg of natural caffeine from yerba mate. Enough to make movement feel happy. Never enough to take you out of it.

And for the recovery side of the ledger, where alcohol does its worst damage, High Performance Sleep Gummies pair 2mg THC with CBD, CBN, magnesium glycinate, and chamomile to support the deep sleep alcohol steals.

If you want to go deeper on how cannabinoids interact with the ECS, our science page breaks down the full mechanism.

Frequently Asked Questions

What does sober curious mean?

Sober curious describes people who deliberately reduce or question their alcohol consumption without identifying as fully sober. Many replace some or all drinking occasions with alternatives like low-dose THC gummies and other hemp-derived products.

Is low-dose THC better than alcohol for athletes?

Alcohol measurably impairs muscle protein synthesis and sleep quality, both critical for recovery. Low-dose THC engages the endocannabinoid system, which research links to exercise enjoyment and mood elevation, without the hangover or recovery cost. Individual responses vary, and neither belongs in your system during competition under some sports policies.

How much THC is a low dose?

Most industry data puts the social sweet spot at 2.5mg to 5mg. OFFFIELD's Energy Gummies contain 3mg per serving, designed for presence and elevation rather than impairment.

Will a 3mg THC gummy get me high?

At 3mg, most people experience mild mood elevation and relaxation rather than a strong high. As our tagline puts it: Run High, Not Stoned.

Movement Made Happy, Hangover Not Included

The sober curious summer is not about restriction. It's about the realization that feeling good tonight and feeling good tomorrow were never supposed to be a trade-off. Your body built an entire system for enjoying movement. Work with it.

Ready to upgrade the post-run ritual? Grab High Performance Energy Gummies for the session and Sleep Gummies for the recovery, and explore more on the OFFFIELD Journal.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. OFFFIELD products are derived from hemp and contain less than 0.3% Delta-9 THC in compliance with the 2018 Farm Bill. Must be 21 or older to purchase. Do not use before driving or operating machinery. Consult your physician before use, especially if subject to athletic drug testing.

article image
Why Elite Athletes Use CBD for Sleep and Recovery

Ask a pro athlete what separates a good season from a great one, and you'll hear less about training and more about what happens between sessions. Sleep is the only performance enhancer that's legal in every league, every country, every sport. And according to a new peer-reviewed study, elite athletes have quietly found a tool to get more of it.

Researchers publishing in Frontiers in Nutrition surveyed elite-level Canadian athletes — competitors on Olympic and Paralympic pathways, the most drug-tested humans on the planet. 38% reported having used CBD. Among those users, the numbers tell a clear story: 93% agreed CBD improved their sleep, 90% said it improved relaxation, and 77% reported reduced pain from training.

These aren't weekend warriors chasing a trend. These are athletes whose careers depend on what their bodies can do tomorrow morning.

The Most Tested Athletes in the World Are Choosing Cannabinoids

Context makes this study remarkable. Elite athletes operate under the World Anti-Doping Agency's microscope, where a single contaminated supplement can erase a career. CBD is the only cannabinoid explicitly removed from WADA's prohibited list — and even so, athletes in the study cited anti-doping concerns as the top reason for caution.

They're using it anyway. Why? Because the recovery math works. The study found 55% of athlete users took CBD in the evening before bed — not before training, not during competition. They're not chasing a high. They're chasing deep sleep, the window where muscle repair, memory consolidation, and hormonal recovery actually happen.

This mirrors earlier findings in professional rugby, where Kasper and colleagues found players used CBD primarily for sleep and recovery, and a growing chorus of researchers arguing in outlets like Scientific American that cannabis prohibition in sport never made scientific sense to begin with.

Your Endocannabinoid System Runs the Recovery Department

Here's the mechanism, because the mechanism matters.

The endocannabinoid system (ECS) is your body's master regulator — a network of receptors (CB1 and CB2) and signaling molecules that governs sleep cycles, inflammation, pain perception, and stress response. It's the same system responsible for the Runner's High. Not endorphins. Endorphins are too large to cross the blood-brain barrier; anandamide, your body's native cannabinoid, is not.

When you train hard, your ECS works overtime. Exercise spikes circulating endocannabinoids, which helps explain the post-workout calm — but intense training blocks, travel, and competition stress can outpace what your body produces on its own. That's where phytocannabinoids come in:

  • CBD interacts with the ECS indirectly, supporting anandamide levels and modulating inflammation — the biological noise that keeps a sore body from settling into deep sleep.
  • CBN (cannabinol) is the sleep specialist. Recent randomized controlled research suggests CBN reduces sleep latency — the time it takes to fall asleep — and reduces nighttime awakenings, without the grogginess of conventional sedatives.
  • THC in precise microdoses (1–2mg) can deepen the early sleep phases where physical restoration concentrates.

Together they create what researchers call the entourage effect: cannabinoids working synergistically, the way the plant evolved them to.

The Dosing Problem Nobody Talks About

Buried in the Frontiers in Nutrition data is the study's most actionable finding. Among elite athletes using CBD, 63% consumed less than 50mg per dose, 27% didn't know their dose at all, and 73% couldn't recall the brand they used. Median confidence in achieving optimal dosing: 35%.

Read that again. The most data-driven athletes alive — people who weigh their food and track their heart rate variability — are guessing at their cannabinoids.

This is the unglamorous frontier of cannabis wellness: not whether cannabinoids work, but whether you know what you're taking. Gas station gummies with mystery doses aren't a recovery protocol. Precision is.

That's the entire premise behind OFFFIELD's High Performance Sleep Gummies: exactly 2mg THC, 20mg CBD, and 20mg CBN per gummy, alongside magnesium glycinate, chamomile, L-theanine, and lavender. A known dose, every night, so your recovery is a system — not a gamble. (The full mechanism breakdown lives on our science page.)

Sleep Is Where Champions Are Made

There's a cultural shift inside this study, too. A generation ago, athletes hid cannabis use behind closed doors while leagues handed out suspensions. In 2026, the WNBA has removed cannabis from its banned list, the NBA and NCAA already have, and elite Olympians are telling researchers — on the record — that cannabinoids help them sleep, relax, and recover.

Notably, athletes in the study disagreed that CBD improved their physical performance or competitiveness directly. They're not looking for a shortcut. They're looking for better recovery, which is to say: they understand that adaptation happens at rest. You don't get stronger during the workout. You get stronger during the sleep that follows it.

The stigma said cannabis makes you lazy. The data says athletes use it to work harder.

Recover Like It's Your Job

Movement made happy includes the part where you stop moving. If the most tested athletes in the world are building cannabinoids into their sleep routine, the question isn't whether it's legitimate — it's whether you're doing it with precision.

Train hard. Sleep deep. Know your dose.

Explore High Performance Sleep Gummies →
Dig into the science of the ECS →
Fuel the other side of the cycle with Energy Gummies →

FAQ

Do cannabis gummies help athletes sleep?

Survey research on elite athletes shows 93% of CBD users report improved sleep. CBN and low-dose THC may further reduce sleep latency and nighttime awakenings.

Is CBD banned for athletes?

No. CBD was removed from WADA's prohibited list in 2018. THC remains restricted in-competition above a 150 ng/mL urinary threshold, which is why precise, low-dose products matter.

What is the endocannabinoid system?

The ECS is a network of receptors and signaling molecules that regulates sleep, inflammation, pain, mood, and stress — and it's the system behind the Runner's High.


These statements have not been evaluated by the Food and Drug Administration. OFFFIELD products are not intended to diagnose, treat, cure, or prevent any disease. Hemp-derived products containing THC may cause impairment; do not drive or operate machinery after use. Must be 21+. Consult your physician before use, especially if you are subject to drug testing, pregnant, nursing, or taking medication. Athletes subject to anti-doping rules should verify product compliance with their governing body.

article image
STAY UP ON THE LATEST